Nyse: hims investigation alert: kessler topaz meltzer & check, llp encourages hims & hers health, inc. (nyse: hims) investors with significant losses to contact the firm

Radnor, pa.--(business wire)-- #classaction--the law firm of kessler topaz meltzer & check, llp (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of hims & hers health, inc. (nyse: hims) (“hims & hers”). on june 23, 2025, during pre-market hours, the pharmaceutical company novo nordisk announced it would no longer provide hims & hers with direct access to its fda-approved weight loss drug wegovy through novocare pharmacy due to.
HIMS Ratings Summary
HIMS Quant Ranking